NCCN Guidelines for Patients® | Diffuse Large B-cell Lymphoma

59 NCCN Guidelines for Patients ® : Diffuse Large B-cell Lymphoma, 2017 Acronyms 3D-CRT three-dimensional conformal radiation therapy 4D-CT four-dimensional computed tomography CAM complementary and alternative medicine CBC complete blood count CNS central nervous system CT computed tomography DLBCL diffuse large B-cell lymphoma DNA deoxyribonucleic acid EBRT external beam radiation therapy FDA Food and Drug Administration FISH fluorescence in situ hybridization FNA fine-needle aspiration GCB germinal center B-cell GVHD graft-versus-host disease GVT graft versus tumor HDT/ASCR high-dose therapy with autologous stem cell rescue HLA human leukocyte antigen IGRT image-guided radiation therapy IHC immunohistochemistry IMRT intensity-modulated radiation therapy IPI International Prognostic Index ISRT involved-site radiation therapy LDH lactate dehydrogenase LINAC linear accelerator MRI magnetic resonance imaging MUGA multi-gated acquisition NCCN National Comprehensive Cancer Network NK cells natural killer cells PET positron emission tomography TLS tumor lysis syndrome Acronyms

RkJQdWJsaXNoZXIy MTE3MTE1